Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer Article

Industry Collaboration International Collaboration

cited authors

  • von Pawel, Joachim; Jotte, Robert; Spigel, David R.; O'Brien, Mary E. R.; Socinski, Mark A.; Mezger, Joerg; Steins, Martin; Bosquee, Leon; Bubis, Jeffrey; Nackaerts, Kristiaan; Trigo, Jose M.; Clingan, Philip; Schuette, Wolfgang; Lorigan, Paul; Reck, Martin; Domine, Manuel; Shepherd, Frances A.; Li, Shaoyi; Renschler, Markus F.

authors

Publication Date

  • December 10, 2014

webpage

published in

category

start page

  • 4012

end page

  • U160

volume

  • 32

issue

  • 35